INVA vs VRTX: Which Stock is Better?

Side-by-side comparison of Innoviva Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

INVA

Innoviva Inc

$24.24

VRTX

Vertex Pharmaceuticals Inc

$441.20

Key Metrics Comparison

MetricINVAVRTXWinner
Market Cap$1.76B$110.81BVRTX
P/E Ratio7.1528.42INVA
EPS (TTM)$3.30$15.33VRTX
Revenue Growth0.2%0.1%INVA
Gross Margin74.9%53.7%INVA

Analyze INVA

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is INVA or VRTX a better investment?

Comparing INVA and VRTX: Innoviva Inc has a market cap of $1.76B while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between INVA and VRTX?

INVA (Innoviva Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: INVA or VRTX?

Based on P/E ratios, INVA trades at a lower multiple (7.2x vs 28.4x).

Which is growing faster: INVA or VRTX?

INVA has higher revenue growth at 0.2% vs 0.1% for VRTX.

Which company is more profitable: INVA or VRTX?

Innoviva Inc (INVA) has higher gross margins at 74.9% compared to 53.7% for VRTX.

Which is the larger company: INVA or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $1.76B for INVA.

Should I buy INVA or VRTX in 2026?

Both INVA and VRTX have investment merit. INVA trades at $24.24 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between INVA and VRTX stock?

Key differences: Market Cap ($1.76B vs $110.81B), P/E Ratio (7.2x vs 28.4x), Revenue Growth (0.2% vs 0.1%), Gross Margin (74.9% vs 53.7%).

Popular Stock Comparisons